Rethinking Ovarian Cancer: Recommendations for Improving Outcomes
By Sebastian Vaughan, J. Coward, Robert C. Bast, Jr., A. Berchuck, J. Berek, James D. Brenton, George Coukos, C. Crum, R. Drapkin, D. Etemadmoghadam and 16 more. Nature Reviews. Cancer, 2011
1,276 citations recorded by the source corpus.
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.
Subfields: Genetics, Obstetrics and Gynecology, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/19094be671312539b48f0ecd51821edb33011129
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Obstetrics and Gynecology
In Reproductive Medicine
Citations in the corpus
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum (2014, background): “Terms such as “müllerian” or “pelvic serous carcinoma” are not recommended because they create confusion for patients, physicians, and medical investigators [11].”